Alliance Wealth Advisors, LLC /UT

Position in GILD — Gilead Sciences, Inc.

CIK 1893261 Centerville, UT

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$1,210,210

-$649,961 QoQ

Shares Held

9,579

-28.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#997

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Alliance Wealth Advisors, LLC /UT holds $8,702,218 across 9 Drug Manufacturers - General names. GILD ranks #3 (13.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	8,284	$2,084,585
2	LLY	ELI LILLY & Co	1,563	$1,874,709
3	GILD	Gilead Sciences, Inc. This page	9,579	$1,210,210
4	JNJ	Johnson & Johnson	4,729	$1,201,024
5	NVO	Novo Nordisk A S	19,167	$918,865
6	MRK	Merck & Co., Inc.	4,342	$557,947
7	NVS	Novartis AG	2,061	$322,999
8	AMGN	Amgen Inc	813	$294,403

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,210,210	9,579	-28.2%	Shares	Other	2026-07-23
2026-03-31	$1,860,171	13,347	-32.3%	Shares	Sole	2026-05-12
2025-12-31	$2,419,328	19,711	-31.7%	Shares	Sole	2026-02-02
2025-09-30	$3,204,348	28,868	-1.8%	Shares	Sole	2025-11-10
2025-06-30	$3,258,580	29,391	+2.5%	Shares	Sole	2025-08-14
2025-03-31	$3,214,266	28,686	-1.1%	Shares	Sole	2025-05-13
2024-12-31	$2,680,485	29,019	-0.5%	Shares	Sole	2025-01-24
2024-09-30	$2,444,522	29,157	+6.8%	Shares	Sole	2024-11-08
2024-06-30	$1,873,327	27,304	+3.1%	Shares	Sole	2024-08-02
2024-03-31	$1,939,220	26,474	+10.3%	Shares	Sole	2024-05-13
2023-12-31	$1,943,591	23,992	+14.0%	Shares	Sole	2024-02-05
2023-09-30	$1,577,786	21,054	+5.4%	Shares	Sole	2023-11-09
2023-06-30	$1,539,781	19,979	+3.7%	Shares	Sole	2023-08-11
2023-03-31	$1,599,246	19,275	+3.2%	Shares	Sole	2023-05-02
2022-12-31	$1,602,905	18,671	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.